Vaccines for Venezuelan equine encephalitis

被引:77
作者
Paessler, Slobodan [1 ]
Weaver, Scott C.
机构
[1] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA
关键词
Vaccines; Togaviridae; Encephalitis; ALPHAVIRUS REPLICON PARTICLES; REGULATORY T-CELLS; GAMMA-DELTA CELLS; VIRUS-INFECTION; SINDBIS VIRUS; ENCEPHALOMYELITIS VIRUS; AIRBORNE CHALLENGE; NONHUMAN-PRIMATES; IN-VITRO; CYTOTOXIC LYMPHOCYTES;
D O I
10.1016/j.vaccine.2009.07.095
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Arboviruses are capable of causing encephalitis in animals and human population when transmitted by the vector or potentially via infectious aerosol. Recent re-emergence of Venezuelan equine encephalitis virus (VEEV) in South America emphasizes the importance of this pathogen to public health and veterinary medicine. Despite its importance no antivirals or vaccines against VEEV are currently available in the USA. Here we review some of the older and newer approaches aimed at generating a safe and immunogenic vaccine as well as most recent data about the mechanistic of protection in animal models of infection. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:D80 / D85
页数:6
相关论文
共 76 条
[1]   Venezuelan equine encephalomyelitis [J].
Beck, CE ;
Wyckoff, RWG .
SCIENCE, 1938, 88 :530-530
[2]   Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus [J].
Bennett, AM ;
Lescott, T ;
Phillpotts, RJ .
VIRAL IMMUNOLOGY, 1998, 11 (03) :109-117
[3]   ATTENUATION OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS BY IN VITRO CULTIVATION IN GUINEA-PIG HEART CELLS [J].
BERGE, TO ;
TIGERTT, WD ;
BANKS, IS .
AMERICAN JOURNAL OF HYGIENE, 1961, 73 (02) :209-&
[4]   γ/δ T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis [J].
Cardona, AE ;
Teale, JM .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3163-3171
[5]   Virus-induced demyelination in nude mice is mediated by γδ T cells [J].
Dandekar, AA ;
Perlman, S .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1255-1263
[6]   ATTENUATED MUTANTS OF VENEZUELAN EQUINE ENCEPHALITIS-VIRUS CONTAINING LETHAL MUTATIONS IN THE PE2 CLEAVAGE SIGNAL COMBINED WITH A 2ND-SITE SUPPRESSOR MUTATION IN E1 [J].
DAVIS, NL ;
BROWN, KW ;
GREENWALD, GF ;
ZAJAC, AJ ;
ZACNY, VL ;
SMITH, JF ;
JOHNSTON, RE .
VIROLOGY, 1995, 212 (01) :102-110
[7]   Alphavirus replicon particles as candidate HIV vaccines [J].
Davis, NL ;
West, A ;
Reap, E ;
MacDonald, G ;
Collier, M ;
Dryga, S ;
Maughan, M ;
Connell, M ;
Walker, C ;
McGrath, K ;
Cecil, C ;
Ping, LH ;
Frelinger, J ;
Olmsted, R ;
Keith, P ;
Swanstrom, R ;
Williamson, C ;
Johnson, P ;
Montefiori, D ;
Johnston, RE .
IUBMB LIFE, 2002, 53 (4-5) :209-211
[8]  
DAVIS NL, 1994, ARCH VIROL S, V9, P99
[9]   Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine [J].
Dupuy, Lesley C. ;
Locher, Christopher P. ;
Paidhungat, Madan ;
Richards, Michelle J. ;
Lind, Cathleen M. ;
Bakken, Russell ;
Parker, Michael D. ;
Whalen, Robert G. ;
Schmaljohn, Connie S. .
VACCINE, 2009, 27 (31) :4152-4160
[10]   Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates [J].
Fine, Donald L. ;
Robert, Brian A. ;
Terpening, Sara J. ;
Mott, Jason ;
Vasconcelos, Daphne ;
House, Robert V. .
VACCINE, 2008, 26 (27-28) :3497-3506